Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508088 | SCV001714009 | uncertain significance | not provided | 2020-09-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002564231 | SCV003020742 | uncertain significance | Nemaline myopathy 2 | 2024-12-02 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 3285 of the NEB protein (p.Arg3285His). This variant is present in population databases (rs376932516, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1163218). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002564230 | SCV003725523 | uncertain significance | Inborn genetic diseases | 2022-08-08 | criteria provided, single submitter | clinical testing | The c.9125G>A (p.R3042H) alteration is located in exon 66 (coding exon 64) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 9125, causing the arginine (R) at amino acid position 3042 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001508088 | SCV003810300 | uncertain significance | not provided | 2019-05-03 | criteria provided, single submitter | clinical testing |